Oncoinvent ASA(DE:7BG)
€6.14+0.30 (+5.14%)
DE:7BG
Oncoinvent ASA earnings date
€6.14
At close:+0.30 (+5.14%)
Oncoinvent ASA (7BG) Q3 2022 Earnings Report
2 Followers
DE:7BG Q3 2022 EPS Results
- Actual EPS
- -EUR 46.57
- Consensus EPS
- -EUR 544.96
- Beat/Miss
- Beat by +EUR 498.39
- One Year Ago EPS
- -EUR 55.61
DE:7BG Q3 2022 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q3 2022
- Date
- 11/15/2022
- Time
- Before Open
- Conference Call
- Tuesday, November 15, 2022
DE:7BG Upcoming Earnings
Oncoinvent ASA's next earnings date is estimated for November 17, 2026, based on past reporting schedules.
Q3 2022 Earnings Call Audio
DE:7BG Q3 2022 Earnings Call
0:00 / 0:00
Q3 2022 Earnings Slide Deck
Q3 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:7BG Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 17, 2026 | 2026 (Q3) | ―- | -8.39 | ― | ― |
| Aug 27, 2026 | 2026 (Q2) | ―-1.44 | -8.39 | 82.88% (+6.95) | |
| May 27, 2026 | 2026 (Q1) | ―- | ― | ― | |
| Feb 26, 2026 | 2025 (Q4) | ―-6.45 | -6.6 | 2.36% (+0.16) | |
| Nov 19, 2025 | 2025 (Q3) | ―- | -0.06 | ― | |
| Aug 27, 2025 | 2025 (Q2) | ―-8.39 | -8.42 | 0.35% (+0.03) | |
| May 21, 2025 | 2025 (Q1) | ―- | -0.09 | ― | |
| Feb 26, 2025 | 2024 (Q4) | -6.60-6.60 | -12.12 | 45.50% (+5.51) | |
| Nov 13, 2024 | 2024 (Q3) | -8.12-3.82 | -6.06 | 37.00% (+2.24) | |
| Aug 21, 2024 | 2024 (Q2) | -7.57-8.42 | -90.88 | 90.73% (+82.46) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
